Tata India Pharma & Healthcare Fund Regular Growth
- Rating N.A.
- Plan
- 5D
- 1M
- 6M
- 1Y
- 5Y
- MAX
Key Metrics
- AUM (in Cr)1287.45
- CAGR 23.45%
- Exit Load0.25%
- Expense ratio2.14%
- CategoryEquity
- Min Investment5000
- Min SIP100
- Launch Date2015-12-28
Asset Allocation
Holdings As On - 10 February 2025
- Name
- Value (Cr)
- Holding %
- Sun Pharmaceutical Industries
- 151.72
- 11.78%
- Aurobindo Pharma
- 98.89
- 7.68%
- Lupin
- 96.65
- 7.51%
- Dr Reddys Laboratories
- 85.34
- 6.63%
- Cipla
- 74.93
- 5.82%
- Divis Laboratories
- 64.02
- 4.97%
- Fortis Healthcare
- 61.56
- 4.78%
- Cash / Net Current Asset
- 61.20
- 4.75%
- Zydus Lifesciences
- 45.80
- 3.56%
- Apollo Hospitals Enterprise
- 42.98
- 3.34%